Comparison of Levobupivacaine and Ropivacaine in Patients Undergoing Forearm Orthopaedic Surgeries under Brachial Plexus Block

A Prospective Randomized Study to compare Levobupivacaine and Ropivacaine in Patients Undergoing Forearm Orthopaedic Surgeries under Ultra Sound Guided Supraclavicular Brachial Plexus Block

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2019/04/018608

Enrollment

Registered

2019-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) grade I & II patients Age group 18- 60 years Patients with BMI 18.5-22.9 kg/m2 Elective cases

Exclusion criteria

Exclusion criteria: Infection at the end site of injection Neuromuscular disorder Patients with pre-existing diseases, cardiovascular or cerebrovascular diseases, Severely altered mental status. Patient converted to general anesthesia intra-operatively.

Design outcomes

Primary

Measure	Time frame
Study the effects of Levobupivacaine versus Ropivacaine in patients undergoing forearm orthopedic surgeries under ultra sound guided supraclavicular brachial plexus block.Timepoint: 18 months	—

Secondary

Measure	Time frame
Sensory block, Motor block , Haemodynamic parameters, and side effects.Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Gurdeep Singh Jheetay

Teerthanker Mahaveer Medical College & Research Center

mukeshkumar2002@gmail.com9837624543

Outcome results